To reach the A.A.I.D.website, and research Dr. Vassos click on the link below.The American Academy of Implant Dentistry was established in 1951 and is the world’s oldest professional organization dedicated to the advancement of dental implant dentistry. Dr. Vassos exclusively uses Nobel Biocare dental implants.Please click on the link below to research the Nobel Biocare company profile and products. Dr. Vassos is a general dentist who maintains a private practice in the historic Le Marchand Mansion in Edmonton, Alberta, Canada.Dr. Vassos graduated from Dentistry at the University of Alberta in 1963.As someone continually looking for advancement in both his personal and professional life, Dr. Vassos made the decision in 1968 to focus his career on the placement and restoration of dental implants.Thoughout this time he has also authored numerous published articles concerning this treatment modality.Dr. Vassos lectures locally and internationally and offers live demonstrations of his surgical techniques to other dentists at his private practice in Edmonton.

As an avid health enthusiast, Dr. Vassos encourages all his patients to focus on their overall health and well being as well as their oral health.Dr. Vassos is a member of the Canadian Dental Association and the Alberta Dental Association and College.Dr. Vassos' Curriculum Vitae, professional credentials and affiliations are available upon request due to existing advertising restrictions by the Alberta Dental Association and College (ADA&C).Dr. Vassos Named Aaron Gershkoff - Norman Goldberg Award WinnerDr.David Vassos D.D.S., a graduate of the University of Alberta in 1963, has been named the Aaron Gershkoff - Norman Goldberg Award winner for 2014.This highest honor awarded by the American Academy of Implant Dentistry (AAID) was presented at its 63rd Annual Educational Conference in Orlando, Florida in November.The AAID is the oldest professional organization in the world dedicated to the advancement of implant dentistry, established in 1951, the organization has more than 4,500 members worldwide.

Dr Vassos is the 42nd individual and the first Canadian to receive this award.Previous recipients include Per-Ingvar Branemark (Sweden), Dr. Leonard Linkow (USA), and Dr. Carl Misch (USA).Since 1968, Dr. Vassos has dedicated his career to placing and restoring dental implants.He has had published 37 professional articles on implant dentistry.He participated in a five year clinical study for the FDA and Canada Health and Welfare which was used for approval for Steri-Oss (now Nobel Biocare) dental implants to be used in both the U.S.A.With Peter Petrick M.D.he conducted a 3-½ year sinus graft study in cooperation with the Division of Oral Pathology, at the General Hospital, Edmonton, and with Dr. Richard Murphy at the University Hospital, Edmonton.In 1978 he developed the one-piece and three piece ramus bar implants.He also designed the DMV blade implants for the Steri-Oss company, and the sinus bar implant.Dr. Vassos currently sits on the Nobel Biocare North American Advisory Council.In 2003 he developed the VIPS surgical implant positioning system, which is in use in many countries.

Dr. Vassos has shared his professional experience and knowledge, having presented over 200 lectures throughout the world, including Italy, Japan, Korea, Mexico, Guatemala, El Salvador.möbel kaufen coesfeldRussia, New Zealand, Australia, Chile, Argentina, Brazil, Germany, the United States and Canada.möbel an und verkauf oscherslebenIn April of 2014, Dr. Vassos was awarded the AAID Lifetime Achievement Award.möbel döbelnNobel Biocare, a world leader in the development of innovative restorative dental solutions, established the chair in 2006 with the intention of enhancing the dental school's training and education programs in implant dentistry.Nobel Biocare (NOBN, SIX Swiss Exchange) is a world leader in innovative restorative and esthetic dental solutions.antike mobel ankauf nrw

As a complete solutions provider, Nobel Biocare offers the most comprehensive range of solutions, from tooth to root, for single tooth to edentulous indications.mobeleinlagerung preiseThe solutions portfolio covers dental implants (including the key brands NobelActive, Brånemark System and NobelReplace), as well as individualized prosthetics and equipment (NobelProcera guided surgery solutions and biomaterials).mobel outlet ruhrgebietNobel Biocare has more than 2,400 employees and recorded revenue of EUR 576.6 million in 2010.roller möbel duisburgThe company is headquartered in Zurich, Switzerland.gebrauchte möbel verkaufen ludwigsburgProduction takes place at seven sites, located in Canada, Israel, Japan, Sweden and the U.S.möbel münchen neuhausen

Nobel Biocare has 34 direct sales organizations.The UCLA School of Dentistry is dedicated to improving the oral health of the people of California, the nation and the world through its teaching, research, patient care and public service initiatives.The school provides education and training programs that develop leaders in dental education, research, the profession and the community; conducts research programs that generate new knowledge, promote oral health and investigate the cause, prevention, diagnosis and treatment of oral disease; and delivers patient-centered oral health care to the community and the state.For more news, visit the UCLA Newsroom and UCLA News|Week and follow us on Twitter.Online Member Centre Cision Communications Cloud Cision PR Edition CisionPoint MediaSource Monitoring/Evaluation Visible Intelligence FastFinder My CNW CNW Access Register for my CNW Search Go !Advanced Search Capital Pro-Égaux Inc.- Capital Pro-Égaux Inc.

(NEX: CPE.H) announces the conclusion of a license agreement with SICAT Gmbh & Co.KG MORIN-HEIGHTS, QC, April 4, 2016 /CNW Telbec/ - Capital Pro-Égaux Inc.(the "Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique d'usinage Sinlab Inc.("Sinlab"), has entered into a Patent License Agreement with SICAT Gmbh & Co.As part of the agreement, Sinlab granted SICAT and its affiliates a non-exclusive and non-transferable worldwide license in and to all of its patents for use in products that SICAT develops or offers commercially, including patents relating to its Technobar and Technoguide technologies, under terms undisclosed for confidentiality reasons.The Company previously announced settlement and/or license agreements that include Biomet 3i, LLC (formerly Implant Innovations, Inc.); Delcam USA, Inc.and Delcam Holdings, Inc.; Cagenix, Inc.; Dentsply International Inc.; Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc.; Biocad Médical Inc.; Nobel Biocare USA, LLC; Nobel Biocare Procera, LLC; 3Shape A/S, exocad America, Inc.

and MIS Implants Technologies, Ltd.The Company is currently pursuing its licensing program with other industry participants.The Company cannot predict the outcome of its ongoing negotiations or of any legal proceedings it may decide to institute against those entities that fail or refuse to contract a license.The decision to take legal proceedings will be based on available information and the Company's assessment of all relevant facts and circumstances, including costs involved with such proceedings.Such costs are unpredictable and may be substantial.Caution regarding forward-looking statements This news release contains certain forward-looking statements regarding the Company's expectation of future events, including potential claims and the institution of legal proceedings.Such expectations are based on certain assumptions based on currently available information.If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this press release.

Factors that could lead actual results to differ include, amongst others, factors that may impact claims and legal proceedings, such as interpretation of factual matters, time and money involved in undertaking legal proceedings, uncertainty as to the final result and other risks.The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by securities laws.Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry.Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of NEX and the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.SOURCE Capital Pro-Égaux Inc.